IntelGenx purchased INT0010 for the management of multiple sclerosis (MS) induced neuropathic pain and other conditions

Cynapsus Therapeutics Inc.

Canada / Small-Cap Biopharma (<$1 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

IntelGenx Corp.

Canada / Small-Cap Biopharma (<$1 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced